SCHEMBL5486873

SCHEMBL5486873

NC(=NO)c1cccc(Oc2ccc3c(c2)S(=O)(=O)N=CN3CCF)c1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
PARP14 Q460N5 2/20 0.34
PARP10 Q53GL7 2/20 0.34
TNKS O95271 1/20 0.34
PARP15 Q460N3 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
KMT2A Q03164 3/20 0.32
LMNA P02545 1/20 0.32
GFER P55789 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GRIA2 P42262 3/20 0.31
POLB P06746 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 2/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5486871 1.00 THRB (0.35) THRBNPSR1PARP14PARP10TNKS
SCHEMBL5486890 0.89 LMNA (0.33) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL5475868 0.80 GRIA2 (0.46) THRBNPSR1KMT2AGRIA2
SCHEMBL5479486 0.76 GRIA2 (0.51) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL5479485 0.73 GRIA2 (0.38) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL5479508 0.73 GRIA2 (0.38) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL5353619 0.71 ALDH1A1 (0.49) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL5353615 0.64 ALDH1A1 (0.38) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL5353634 0.64 ALDH1A1 (0.38) PARP14PARP10TNKSPARP15TNKS2
SCHEMBL1973344 0.63 TNKS (0.38) PARP14PARP10TNKSPARP15TNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655030-B1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same SERVIER LAB (FR) 2007-12-19 EP disclosed
US-20070270415-A1 Benzothiadiazine compounds LESLABORATOIRES SERVIER (FR) 2007-11-22 US disclosed
US-7268130-B2 Benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2007-09-11 US disclosed
EP-1655030-A1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same Les Laboratoires Servier (FR) 2006-05-10 EP disclosed
US-20060094712-A1 New benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270415-A1 Benzothiadiazine compounds SLC1A1, SLC1A2, SULT2A1 THRB 914/4885NPSR1 347/4885PARP14 1768/4885
US-20060094712-A1 New benzothiadiazine compounds SLC1A1, SLC1A2, GABRA5 THRB 917/4885NPSR1 288/4885PARP14 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.